Dual sourcing a drug substance is one of the clearest risk decisions a pharmaceutical supply chain can make. Regulators encourage supply resilience, shortage frameworks in several markets ask manufacturers to demonstrate continuity planning, and the operational logic is obvious: a single site, a single regulatory filing and a single customs route concentrate an enormous amount of commercial risk.
What is far less clear is whether a given second source would actually work. The qualification package may be three years old. The alternate site may have changed a critical process parameter under its own change control without triggering a notice to you. The capacity you assumed was reserved may exist only as a sentence expressing an intention to discuss volumes in good faith. None of that shows up in a supplier list that records the site as qualified.
The gap is contractual rather than technical. Qualification is a quality activity with an owner and a file. The obligations that keep qualification current, keep capacity available and define how fast the alternate can be switched on are commercial terms scattered across a supply agreement, a quality agreement and sometimes a separate capacity reservation. They are rarely tracked as a single set with dates and owners.
Why second sources go stale
These are the recurring failure modes in dual-sourcing programs, and they cluster in the years after the qualification project closes.
- Undefined activation lead time, the agreement says the supplier will use reasonable efforts to supply on request, which converts a resilience plan into a negotiation during a crisis.
- Qualification decay, no periodic requalification duty exists, so the alternate site process, equipment and personnel drift away from the state that was assessed.
- Filing and contract divergence, the regulatory filing still lists the alternate source while the commercial agreement has lapsed or narrowed to a different material grade.
- Capacity that was never reserved, the supplier has other customers, the volume language is aspirational, and the alternate is unavailable precisely when the market is tight.
- No standby economics, the alternate receives no volume and no fee, loses interest in maintaining readiness, and quietly deprioritizes your change notifications.
Each of these is an obligation problem, not a sourcing problem. The organization already decided it wanted a second source and paid for the qualification work. What it did not do was write down, in terms someone can monitor, what both parties must keep doing so the option stays exercisable. The same discipline that keeps recurring quality agreement obligations from slipping is exactly what a standby source needs.
Write it as a number with a start trigger and a defined deliverable. For example: within ninety days of written notice, the supplier shall deliver a first commercial batch meeting the agreed specification, using the process and equipment described in the qualification package in effect at the date of notice. Vague effort language in this clause makes every other term in the agreement less useful, because the option cannot be priced or planned around.
The obligation set that keeps an alternate source real
Five obligation families do the work. Each needs an owner, a cadence and an evidence artifact, and each should be visible in the same register as your primary supply commitments.
- Qualification maintenance. A periodic requalification duty with a stated interval, plus a requirement that the supplier notify you before any change to process, site, equipment or subcontractor affecting the qualified state.
- Regulatory support duties. Commitments to maintain the drug master file or equivalent, grant right of reference, supply data packages for variations, and support inspections at the alternate site within a defined response time.
- Capacity and activation. Reserved or committed capacity expressed in units per period, an activation lead time with a start trigger, and a first-batch deliverable defined against a specific qualification package.
- Standby economics. Minimum annual purchase, a reservation fee, or a periodic demonstration batch. Something must flow to the supplier so readiness is commercially rational for them, not charity.
- Data and sample obligations. Retained samples, stability data on the alternate material, and analytical method transfer maintenance, so a switch does not trigger an unplanned comparability exercise.
A five-step roadmap for making a second source exercisable
Step 1, Define the activation scenario before the commercial terms
Write the scenario you are buying protection against, including the volume you would need, the notice you would realistically be able to give and the period you would need to cover. Terms negotiated without that scenario tend to protect against a shortage nobody modeled.
Step 2, Negotiate activation lead time and capacity as a pair
Lead time without capacity is an empty promise and capacity without lead time is unusable. Agree both as numbers, with the qualification package referenced explicitly, and state what happens if the supplier cannot meet the committed volume when called.
Step 3, Price the standby and put it in the budget
Decide whether readiness is bought through minimum volume, a reservation fee or scheduled demonstration batches, then fund it as a line item. Programs that skip this step consistently find the alternate has lost readiness within two to three years.
Step 4, Register the obligations with owners and dates
Requalification intervals, change notification duties, regulatory support response times, demonstration batch dates and fee payment dates all belong in the obligation register with named owners, not in a quality manual appendix.
Step 5, Reconcile filing status to contract status annually
Run one review each year that puts the regulatory filing, the qualification file and the commercial agreement side by side for every alternate source. Where the three disagree, either fix the contract or stop describing the site as a second source.
See supply obligations tracked as live work
Requalification intervals, change notifications and activation commitments monitored with owners and dates, not filed and forgotten.
Where quality agreements and supply agreements have to meet
Dual sourcing is one of the clearest cases where splitting obligations across a quality agreement and a supply agreement creates real exposure. The quality agreement typically governs change notification, deviation handling, audit rights and documentation retention. The supply agreement governs volume, price, lead time and remedies. An alternate source needs both to point the same way: a change notification duty is close to worthless if the supply agreement permits the supplier to substitute a subcontractor without consequence, and a committed activation lead time is undeliverable if the quality agreement allows a requalification cycle longer than the lead time itself. The practical fix is a single obligation register drawn from both documents, with conflicts surfaced as findings rather than discovered during an activation. Industry practice increasingly treats this reconciliation as a standing annual control rather than a project task, and it pairs naturally with obligation management for life sciences.
Obligation register entries for a standby source
The pattern below shows what a monitorable second source looks like once the commitments are extracted from both agreements.
| Obligation | Cadence or trigger | Owner | Evidence |
|---|---|---|---|
| Requalification of alternate site | Every twenty-four months | Supplier quality | Signed requalification report |
| Change notification before implementation | On supplier change event | Supplier quality | Notification with impact assessment |
| Regulatory data package on request | Within thirty days of request | Regulatory affairs | Submitted package and acknowledgement |
| Reserved capacity confirmation | Annual, against forecast | Supply planning | Written capacity confirmation |
| Demonstration or standby batch | Annual or per agreement | Manufacturing | Batch record and release data |
A second source is an option, and options have maintenance costs. The organizations that get value from dual sourcing treat the agreement as a set of live commitments rather than a document filed after a qualification project. They define activation lead time as a number, buy capacity explicitly, fund readiness through volume or fees, put every recurring duty into a register with an owner and a date, and reconcile the commercial agreement against the regulatory filing once a year. That is a modest amount of ongoing work, and it is the difference between a genuine supply option and an entry on a slide that does not survive contact with a shortage.
For related guidance, see GxP supplier qualification, contract controls that hold, The sponsor’s guide to CRO master service agreements and The quality leader’s guide to CMO quality agreements.
